Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2- Inhaled Milrinone Prevents the Increase in Pulmonary Artery Pressure After CPB

NCT00819377 is registered in ClinicalTrials.gov with Andre Denault as lead sponsor.

NCT NCT00819377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00819377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2- Inhaled Milrinone Prevents the Increase in Pulmonary Artery Pressure After CPB
Lead sponsor
Andre Denault
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
December 31, 2012
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, hypertension, pulmonary, valvular insufficiency, valvular stenosis